1 document found, page 1 of 1

Sort by Issue Date
go first page go previous page
go to page: 1
go next page go last page
rss feed search results

Design and Rationale of the Non-Interventional, Edoxaban Treatment in RoutiNe C...

Cohen, A; Ay, C; Hainaut, P; Décousus, H; Hoffmann, U; Gaine, S; Coppens, M; Marques da Silva, P; Jimenez Castro, D; Amann-Vesti, B; Brüggenjürgen, B

BACKGROUND: Venous thromboembolism (VTE, including deep vein thrombosis [DVT] and pulmonary embolism [PE]) has an annual incidence rate of 104-183 per 100,000 person-years. After a VTE episode, the two-year recurrence rate is about 17%. Consequently, effective and safe anticoagulation is paramount. Edoxaban is a direct oral anticoagulant (DOAC) approved VTE treatment. Current safety and efficacy data are derive...

Date: 2018   |   Origin: Repositório do Centro Hospitalar de Lisboa Central, EPE
More info.
go first page go previous page
go to page: 1
go next page go last page
rss feed search results

1 Results

Queried text

Refine Results

Author





















Date


Document Type


Access rights


Resource


Subject